EMBLA — Embla Medical hf Cashflow Statement
0.000.00%
Last trade - 00:00- DKK14.60bn
- DKK17.44bn
- $854.89m
- 96
- 23
- 39
- 51
Annual cashflow statement for Embla Medical hf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 28.3 | 97.3 | 64.8 | 89.4 | 113 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 5.25 | 0.115 | 8.89 | -9.58 | 5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.746 | -48.4 | -62.3 | -35.4 | -58.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 92.2 | 101 | 60.8 | 94.3 | 116 |
| Capital Expenditures | -24 | -26.7 | -25.9 | -42.3 | -39.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -82.4 | -32.8 | -40.3 | -14.9 | -65.5 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -106 | -59.4 | -66.3 | -57.1 | -105 |
| Financing Cash Flow Items | -2.59 | -1.33 | -0.63 | -0.759 | -9.65 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 51.9 | -51.1 | 3.79 | -41 | 5.76 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 43.8 | -17.2 | -8.56 | -3.98 | 13.5 |